Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage

Carcinogenesis

Volumn 23, Issue 6, 2002, Pages 1057-1064

  Peitsaro, Panu ^a   Hietanen, Sakari ^a,b   Johansson, Bo ^a   Lakkala, Taina ^a   Syrjänen, Stina ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; VIRUS DNA;

ARTICLE; CELL CLONE; CELL GROWTH; CELL LINE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 5P; CHROMOSOME BAND; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA FLANKING REGION; DNA INTEGRATION; DYSPLASIA; EPISOME; EPITHELIUM CELL; GENE DELETION; GENETIC VARIABILITY; GENITAL TRACT TUMOR; GENOME; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; KARYOTYPE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; SEQUENCE HOMOLOGY; TUMOR GROWTH; VAGINA DISEASE; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION; VIRUS STRAIN; VIRUS TYPING; WART VIRUS;

EID: 0036313215     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.6.1057     Document Type: Article

References (67)

1. Papillomavirus infections-a major cause of human cancers
2. Epidemiology of genital HPV infections, CIN and cerviacal cancer
3. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ
4. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours
5. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines
6. Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180
7. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells
8. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours
9. Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer
10. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis
11. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes and cancer chromosome breakpoints
12. Viral integration, fragile sites and proto-oncogenes in human neoplasia
13. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines
14. Genetic alterations by human papillomaviruses in oncogenesis
15. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: Direct evidence for the coincidence of viral integration sites and fragile sites
16. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16
17. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis
18. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells
19. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
20. Association of human papillomavirus type 16 and 18 E6 proteins with p53
21. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
22. Repression of p53 transcriptional activity by the HPV E7 proteins
23. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies
24. Activation of p53 in cervical carcinoma cells by small molecules
25. Isolation of two keratinocyte cell lines derived from HPV-positive dysplastic vaginal lesions
26. A novel type of human papillomavirus associated with genital neoplasias
27. Human papillomavirus type 33 in tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites
28. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
29. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer
30. Intratype variation in 12 human papillomavirus types: A worldwide perspective
31. Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progessing towards a malignant phenotype
32. A simple salting out procedure for extractin DNA from human nucleated cells
33. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes
34. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites
35. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity
36. Alterations in physical state and expression of human papillomavirus type 18 DNA following crisis and establishment of immortalized ectocervical cells
37. Structural and expressional alterations of episomal and integrated human papillomavirus type 16 in precancerous lesions and carcinomas of the cervix
38. Expression of HPV16 E6 or E7 increases integration of foreign DNA
39. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas
40. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization
41. Rearrangement of both alleles of human chromosome 8 in HeLa cells, one of them as a result of papillomavirus DNA
42. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines
43. Integration site of human papillomavirus type-18 DNA in chromosome band 8q22.1 of C4-I cervical carcinoma: Dnase I hypersensitivity and methylation of cellular flanking sequences
44. Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines
45. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites
46. Fragile sites are targets of diverse mutagenes and carcinogens
47. Multiple recurrent genomic rearrangements and fragile sites in human cancer
48. Common fragile sites and cancer
49. The human homolog of the Moloney leukemia virus integration 2 locus (MLV12) maps to band p14 of chromosome 5
50. Deletion in human chromosome region 12q13-15 by integration of human papillomavirus DNA in a cervical carcinoma cell line
51. Human papillomavirus type 16 DNA is integrated into chromosome region 12q14-q15 in a cell line derived from a vulvar intraepithelial neoplasia
52. Recurrent integration of papillomavirus DNA within the human 12q14-15 uterine breakpoint region in genital carcinomas
53. Cumulative gene and chromosome alterations associated with in vitro neoplastic transformation of human cervical cells
54. High resolution analysis of chromosome 3p alterations in cervical carcinoma
55. Preferential sites for viral integration on mammalian genome
56. Chromosome changes in 43 carcinomas of the cervix uteri
57. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q
58. Herpes simplex virus and human papillomavirus sites correlate with chromosomal breakpoints in human cervical carcinoma
59. Frequent viral integration in topologically destablished and transcriptionally active chromosomal regions
60. Complex genomic rearrangement within the 12q15 multiple aberration region induced by integrated human papillomavirus 18 in a cervical carcinoma cell line
61. Genomic cloning and characterization of the nonoccupied allele corresponging to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa
62. A new concept in (adenoviral) oncogenesis: Integration of foreign DNA and its consequences
63. Site-specific integration by adeno-associated virus
64. Immortalization of human cervical keratinocytes by human papillomavirus type 33
65. Viral integration sites in human papilloma virus-33-immortalized cervical keratinocyte cell lines
66. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality